Cocaine addiction presents a significant challenge in treatment, as there are currently no FDA-approved medications specifically for its management. However, various pharmacotherapies are being explored to mitigate cravings and reduce relapse rates. Medications such as antidepressants, dopamine agonists, and anti-anxiety drugs can be used to treat the underlying neurochemical imbalances associated with cocaine addiction. Behavioral therapies, such as cognitive-behavioral therapy (CBT), are often integrated with pharmacological interventions to address the psychological components of addiction. Combining pharmacotherapy with psychosocial treatments has shown promise in improving long-term recovery outcomes for individuals with cocaine addiction.
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College and NEALAC Clinic , United States
Title : The effect of Balint training on self-efficacy and empathy among medical students and the moderator role of personality traits and choice of specialty
Meni Koslowsky, Ariel University, Israel
Title : Sexualizing anxiety and anxiolytic sex: Misattribution of arousal
Sam Vaknin, Commonwealth Institute of Advanced Professional Studies, United Kingdom
Title : Dr Jekyll and Mr. Hyde revealed: Tales from the default mode network
Christopher Ashton, TeDDs on Chapel, Centre for Recovery, Canada
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Addiction and the failure of meaning-forming
Jenni Guentcheva, GoodNeighbor LLC, United States